Interleukin-6 Mediates the Increase in NADPH-Oxidase in the Ketamine Model of Schizophrenia

The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology

Bedard, K., & Krause, K.-H. (2007) · Physiological Reviews · doi:10.1152/physrev.00044.2005 · Cited by 6,989 · see citing works

Cortical inhibitory neurons and schizophrenia

Lewis, D. A., Hashimoto, T., & Volk, D. W. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1648 · Cited by 2,297 · see citing works

Maternal Immune Activation Alters Fetal Brain Development through Interleukin-6

Smith, S. E. P., Li, J., Garbett, K., Mirnics, K., & Patterson, P. H. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2178-07.2007 · Cited by 1,605 · see citing works

The Neuropsychopharmacology of Phencyclidine: From NMDA Receptor Hypofunction to the Dopamine Hypothesis of Schizophrenia

Jentsch, J., & Roth, R. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00060-8 · Cited by 1,349 · see citing works

NMDA Receptor Hypofunction Produces Opposite Effects on Prefrontal Cortex Interneurons and Pyramidal Neurons

Homayoun, H., & Moghaddam, B. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2213-07.2007 · Cited by 1,231 · see citing works

Cytokine Mechanisms of Central Sensitization: Distinct and Overlapping Role of Interleukin-1β, Interleukin-6, and Tumor Necrosis Factor-α in Regulating Synaptic and Neuronal Activity in the Superficial Spinal Cord

Kawasaki, Y., Zhang, L., Cheng, J.-K., & Ji, R.-R. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3338-07.2008 · Cited by 1,162 · see citing works

NMDA receptor hypofunction model of schizophrenia

Olney, J. W., Newcomer, J. W., & Farber, N. B. (1999) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(99)00029-1 · Cited by 1,020 · see citing works

Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics.

Akbarian, S. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950160008002 · Cited by 1,002 · see citing works

Gene Expression Deficits in a Subclass of GABA Neurons in the Prefrontal Cortex of Subjects with Schizophrenia

Hashimoto, T., Volk, D. W., Eggan, S. M., Mirnics, K., Pierri, J. N., Sun, Z., Sampson, A. R., & Lewis, D. A. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-15-06315.2003 · Cited by 938 · see citing works

Ketamine-Induced Loss of Phenotype of Fast-Spiking Interneurons Is Mediated by NADPH-Oxidase

Behrens, M. M., Ali, S. S., Dao, D. N., Lucero, J., Shekhtman, G., Quick, K. L., & Dugan, L. L. (2007) · Science · doi:10.1126/science.1148045 · Cited by 585 · see citing works

Glutamate and Schizophrenia: Phencyclidine, N‐Methyl‐d‐Aspartate Receptors, and Dopamine–Glutamate Interactions

Javitt, D. C. (2007) · International review of neurobiology · doi:10.1016/s0074-7742(06)78003-5 · Cited by 563 · see citing works

N-Acetyl Cysteine as a Glutathione Precursor for Schizophrenia—A Double-Blind, Randomized, Placebo-Controlled Trial

Berk, M., Copolov, D., Dean, O., Lu, K., Jeavons, S., Schapkaitz, I., Anderson-Hunt, M., Judd, F., Katz, F., Katz, P., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.03.004 · Cited by 552 · see citing works

Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo

Do, K. Q., Trabesinger, A. H., Kirsten‐Krüger, M., Lauer, C. J., Dydak, U., Hell, D., Holsboer, F., Boesiger, P., & Cuénod, M. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00229.x · Cited by 540 · see citing works

Prenatal Infection as a Risk Factor for Schizophrenia

Brown, A. S. (2006) · Schizophrenia Bulletin · doi:10.1093/schbul/sbj052 · Cited by 540 · see citing works

Interleukin-6 (IL-6)—A molecule with both beneficial and destructive potentials

Gadient, R. A., & Otten, U. (1997) · Progress in Neurobiology · doi:10.1016/s0301-0082(97)00021-x · Cited by 481 · see citing works

Adult brain and behavioral pathological markers of prenatal immune challenge during early/middle and late fetal development in mice

Meyer, U., Nyffeler, M., Yee, B. K., Knuesel, I., & Feldon, J. (2008) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2007.09.012 · Cited by 457 · see citing works

Parvalbumin-immunoreactive neurons are reduced in the prefrontal cortex of schizophrenics

BEASLEY, C., & REYNOLDS, G. (1997) · Schizophrenia Research · doi:10.1016/s0920-9964(96)00122-3 · Cited by 426 · see citing works

Contrasting Roles of NADPH Oxidase Isoforms in Pressure-Overload Versus Angiotensin II–Induced Cardiac Hypertrophy

Byrne, J., Grieve, D., Bendall, J. K., Li, J., Gove, C. D., Lambeth, J. D., Cave, A. C., & Shah, A. M. (2003) · Circulation Research · doi:10.1161/01.res.0000099504.30207.f5 · Cited by 411 · see citing works

Cysteine regulation of protein function – as exemplified by NMDA-receptor modulation

Lipton, S. A., Choi, Y.-B., Takahashi, H., Zhang, D., Li, W., Godzik, A., & Bankston, L. A. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(02)02245-2 · Cited by 375 · see citing works

A Specific Role for NR2A-Containing NMDA Receptors in the Maintenance of Parvalbumin and GAD67 Immunoreactivity in Cultured Interneurons

Kinney, J. W., Davis, C. N., Tabarean, I., Conti, B., Bartfai, T., & Behrens, M. M. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4722-05.2006 · Cited by 329 · see citing works

GAD67-Mediated GABA Synthesis and Signaling Regulate Inhibitory Synaptic Innervation in the Visual Cortex

Chattopadhyaya, B., Cristo, G. D., Wu, C. Z., Knott, G. W., Kuhlman, S. J., Fu, Y., Palmiter, R. D., & Huang, Z. J. (2007) · Neuron · doi:10.1016/j.neuron.2007.05.015 · Cited by 326 · see citing works

Altered glutathione redox state in schizophrenia.

Yao, J. K., Leonard, S., & Reddy, R. (2006) · Disease Markers · doi:10.1155/2006/248387 · Cited by 321 · see citing works

A Review of the Fetal Brain Cytokine Imbalance Hypothesis of Schizophrenia

Meyer, U., Feldon, J., & Yee, B. K. (2008) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn022 · Cited by 318 · see citing works

Interleukin‐6: a cytokine to forget

Balschun, D., Wetzel, W., del Rey, A., Pitossi, F. J., Schneider, H., Zuschratter, W., & Besedovsky, H. O. (2004) · The FASEB Journal · doi:10.1096/fj.04-1625fje · Cited by 317 · see citing works

Impaired glutathione synthesis in schizophrenia: Convergent genetic and functional evidence

Gysin, R., Kraftsik, R., Sandell, J., Bovet, P., Chappuis, C., Conus, P., Deppen, P., Preisig, M., Ruiz, V., Steullet, P., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706778104 · Cited by 309 · see citing works

Interleukin-6 Facilitates Lipopolysaccharide-Induced Disruption in Working Memory and Expression of Other Proinflammatory Cytokines in Hippocampal Neuronal Cell Layers

Sparkman, N. L., Buchanan, J. B., Heyen, J. R. R., Chen, J., Beverly, J. L., & Johnson, R. W. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3376-06.2006 · Cited by 307 · see citing works

NMDA receptor channels: Subunit-specific potentiation by reducing agents

Köhr, G., Eckardt, S., Lüddens, H., Monyer, H., & Seeburg, P. H. (1994) · Neuron · doi:10.1016/0896-6273(94)90311-5 · Cited by 255 · see citing works

A Pharmacological Model for Psychosis Based on N-methyl-D-aspartate Receptor Hypofunction: Molecular, Cellular, Functional and Behavioral Abnormalities

Rujescu, D., Bender, A., Keck, M. E., Hartmann, A. M., Ohl, F., Ræder, H., Giegling, I., Genius, J., McCarley, R. W., Möller, H., et al. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.08.029 · Cited by 239 · see citing works

Induction of Metabolic Hypofunction and Neurochemical Deficits after Chronic Intermittent Exposure to Phencyclidine: Differential Modulation by Antipsychotic Drugs

Cochran, S. M., Kennedy, M., McKerchar, C. E., Steward, L. J., Pratt, J. A., & MORRIS, B. J. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300031 · Cited by 236 · see citing works

Schizophrenia and Oxidative Stress: Glutamate Cysteine Ligase Modifier as a Susceptibility Gene

Tosic, M., Ott, J., Barral, S., Bovet, P., Deppen, P., Gheorghita, F., Matthey, M.-L., Parnas, J., Preisig, M., Saraga, M., et al. (2006) · The American Journal of Human Genetics · doi:10.1086/507566 · Cited by 234 · see citing works

Repeated application of ketamine to rats induces changes in the hippocampal expression of parvalbumin, neuronal nitric oxide synthase and cFOS similar to those found in human schizophrenia

Keilhoff, G., Becker, A., Grecksch, G., Wolf, G. L., & Bernstein, H. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.03.039 · Cited by 200 · see citing works

A carboxyfullerene SOD mimetic improves cognition and extends the lifespan of mice

Quick, K. L., Ali, S. S., Arch, R. H., Xiong, C., Wozniak, D. F., & Dugan, L. L. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.09.014 · Cited by 184 · see citing works

Profound increase in sensitivity to glutamatergic‐ but not cholinergic agonist‐induced seizures in transgenic mice with astrocyte production of IL‐6

Samland, H., Huitrón‐Reséndiz, S., Masliah, E., Criado, J. R., Henriksen, S. J., & Campbell, I. L. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10635 · Cited by 178 · see citing works

Postnatal Phencyclidine Administration Selectively Reduces Adult Cortical Parvalbumin-Containing Interneurons

Wang, C. Z., Yang, S. F., Xia, Y., & Johnson, K. M. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301647 · Cited by 161 · see citing works

The effects of maternal inflammation on neuronal development: possible mechanisms

Jonakait, G. M. (2007) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2007.08.017 · Cited by 141 · see citing works

Nitric oxide <i>S</i> -nitrosylates serine racemase, mediating feedback inhibition of <scp>d</scp> -serine formation

Mustafa, A. K., Kumar, M., Selvakumar, B., Ho, G. P. H., Ehmsen, J. T., Barrow, R. K., Amzel, L. M., & Snyder, S. H. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611620104 · Cited by 136 · see citing works

Induction of Interleukin-6 by Depolarization of Neurons

Sallmann, S., Jüttler, E., Prinz, S., Petersen, N., Knopf, U., Weiser, T., & Schwaninger, M. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-23-08637.2000 · Cited by 122 · see citing works

Interleukin‐6 inhibits neurotransmitter release and the spread of excitation in the rat cerebral cortex

D’Arcangelo, G., Tancredi, V., Onofri, F., D’Antuono, M., Giovedı̀, S., & Benfenati, F. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00011.x · Cited by 117 · see citing works

Effects of Noncompetitive NMDA Receptor Blockade on Anterior Cingulate Cerebral Blood Flow in Volunteers with Schizophrenia

Holcomb, H. H., Lahti, A. C., Medoff, D. R., Cullen, T. J., & Tamminga, C. A. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300824 · Cited by 108 · see citing works

Prolonged exposure to NMDAR antagonist suppresses inhibitory synaptic transmission in prefrontal cortex

Zhang, Y., Behrens, M. M., & Lisman, J. E. (2008) · Journal of Neurophysiology · doi:10.1152/jn.00079.2008 · Cited by 107 · see citing works

Acute and delayed effects of phencyclidine upon mRNA levels of markers of glutamatergic and GABAergic neurotransmitter function in the rat brain

Cochran, S. M., Fujimura, M., MORRIS, B. J., & Pratt, J. A. (2002) · Synapse · doi:10.1002/syn.10126 · Cited by 85 · see citing works

Transitory glutathione deficit during brain development induces cognitive impairment in juvenile and adult rats: Relevance to schizophrenia

Cabungcal, J.-H., Preissmann, D., Delseth, C., Cuénod, M., Kim, Q., & Schenk, F. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.03.001 · Cited by 83 · see citing works

The Risk for Schizophrenia From Childhood and Adult Infections

Brown, A. S. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07101637 · Cited by 80 · see citing works

Reactive Oxygen Species Inhibit High‐Affinity Glutamate Uptake: Molecular Mechanism and Neuropathological Implications

Volterra, A., Trotti, D., FLORIDI, S., & Racagni, G. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb21800.x · Cited by 73 · see citing works

Bilateral blockade of NMDA receptors in anterior thalamus by dizocilpine (MK‐801) injures pyramidal neurons in rat retrosplenial cortex

Tomitaka, S., Tomitaka, M., Tolliver, B. K., & Sharp, F. R. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00018.x · Cited by 69 · see citing works

NMDA receptor subunit expression in GABAergic interneurons in the prefrontal cortex: Application of laser microdissection technique

Xi, D., Keeler, B. E., Zhang, W., Houlé, J. D., & Gao, W. (2008) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2008.09.013 · Cited by 66 · see citing works

Effect of MK-801 and ketamine on hydroxyl radical generation in the posterior cingulate and retrosplenial cortex of free-moving mice, as determined by in vivo microdialysis

Zuo, D., Wu, Y., Yao, W.-X., Cao, Y., Wu, C., & Tanaka, M. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.05.010 · Cited by 61 · see citing works

Repeated phencyclidine in monkeys results in loss of parvalbumin-containing axo-axonic projections in the prefrontal cortex

Morrow, B. A., Elsworth, J. D., & Roth, R. H. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0708-0 · Cited by 61 · see citing works

Amino terminal domain regulation of NMDA receptor function

Herin, G. A., & Aizenman, E. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.07.015 · Cited by 55 · see citing works

Modulation of oxygen-radical-scavenging enzymes by oxidative stress in primary cultures of rat astroglial cells

Pinteaux, E., Copin, J.-C., Ledig, M., & Tholey, G. (2009) · Developmental Neuroscience · doi:10.1159/000111433 · Cited by 51 · cited 1× · see citing works

Selective increases in the cytokine, TNFα, in the prefrontal cortex of PCP-treated rats and human schizophrenic subjects: influence of antipsychotic drugs

Paterson, G., Ohashi, Y., Reynolds, G. P., Pratt, J. A., & MORRIS, B. J. (2006) · Journal of Psychopharmacology · doi:10.1177/0269881106062025 · Cited by 41 · see citing works

Oxidative Stress after Subarachnoid Hemorrhage in gp91phox Knockout Mice

Liu, S., Tang, J., Ostrowski, R. P., Titova, E., Monroe, C. E., Chen, W., Lo, W., Martin, R., & Zhang, J. H. (2007) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s031716710000682x · Cited by 32 · see citing works

Interneuron dysfunction in psychiatric disorders

Marín, O. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3155 · Cited by 1,190 · see citing works

Pathways underlying neuroprogression in bipolar disorder: Focus on inflammation, oxidative stress and neurotrophic factors

Berk, M., Kapczinski, F., Andreazza, A. C., Dean, O. M., Giorlando, F., Maes, M., Yücel, M., Gama, C. S., Dodd, S., Dean, B., et al. (2011) · Neuroscience &amp; Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.10.001 · Cited by 1,178 · see citing works

Proliferative Neural Stem Cells Have High Endogenous ROS Levels that Regulate Self-Renewal and Neurogenesis in a PI3K/Akt-Dependant Manner

Le Belle, J. E., Orozco, N. M., Paucar, A. A., Saxe, J. P., Mottahedeh, J., Pyle, A. D., Wu, H., & Kornblum, H. I. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2010.11.028 · Cited by 789 · see citing works

Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia

Fillman, S. G., Cloonan, N., Catts, V. S., Miller, L. C., Wong, J., McCrossin, T., Cairns, M., & Weickert, C. S. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.110 · Cited by 609 · see citing works

Ketamine-Induced Loss of Phenotype of Fast-Spiking Interneurons Is Mediated by NADPH-Oxidase

Behrens, M. M., Ali, S. S., Dao, D. N., Lucero, J., Shekhtman, G., Quick, K. L., & Dugan, L. L. (2007) · Science · doi:10.1126/science.1148045 · Cited by 585 · see citing works

Oxidative Stress and Psychological Disorders

Salim, S. (2014) · Current Neuropharmacology · doi:10.2174/1570159x11666131120230309 · Cited by 557 · see citing works

Animal models of cognitive dysfunction and negative symptoms of schizophrenia: Focus on NMDA receptor antagonism

Neill, J. C., Barnes, S. A., Cook, S., Grayson, B., Idris, N. F., McLean, S. L., Snigdha, S., Rajagopal, L., & Harte, M. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.07.004 · Cited by 525 · see citing works

Oxidative stress in schizophrenia: An integrated approach

Bitanihirwe, B. K. Y., & Woo, T.-U. W. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.10.008 · Cited by 474 · see citing works

NOX Enzymes in the Central Nervous System: From Signaling to Disease

Sorce, S., & Krause, K. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2578 · Cited by 472 · see citing works

Cytokines in bipolar disorder vs. healthy control subjects: A systematic review and meta-analysis

Munkholm, K., Braüner, J. V., Kessing, L. V., & Vinberg, M. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.05.018 · Cited by 402 · see citing works

The Classification of Microglial Activation Phenotypes on Neurodegeneration and Regeneration in Alzheimer’s Disease Brain

Varnum, M. M., & Ikezu, T. (2012) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-012-0181-2 · Cited by 393 · see citing works

Redox dysregulation, neurodevelopment, and schizophrenia

Do, K. Q., Cabungcal, J. H., Frank, A., Steullet, P., & Cuenod, M. (2009) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2009.05.001 · Cited by 384 · see citing works

Oxidative stress-driven parvalbumin interneuron impairment as a common mechanism in models of schizophrenia

Steullet, P., Cabungcal, J.-H., Coyle, J., Didriksen, M., Gill, K., Grace, A. A., Hensch, T. K., LaMantia, A.-S., Lindemann, L., Maynard, T. M., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.47 · Cited by 360 · see citing works

Mitochondrial Dysfunction in Depression

Bansal, Y., & Kuhad, A. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666160229114755 · Cited by 355 · see citing works

Interleukin-6, a mental cytokine

Spooren, A., Kolmus, K., Laureys, G., Clinckers, R., De Keyser, J., Haegeman, G., & Gerlo, S. (2011) · Brain Research Reviews · doi:10.1016/j.brainresrev.2011.01.002 · Cited by 352 · see citing works

Interleukin 18 in the CNS

Alboni, S., Cervia, D., Sugama, S., & Conti, B. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-9 · Cited by 301 · see citing works

Importance of selenium and selenoprotein for brain function: From antioxidant protection to neuronal signalling

Solovyev, N. D. (2015) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2015.09.003 · Cited by 282 · see citing works

New Insights on <i>NOX</i> Enzymes in the Central Nervous System

Nayernia, Z., Jaquet, V., & Krause, K.-H. (2014) · Antioxidants &amp; Redox Signaling · doi:10.1089/ars.2013.5703 · Cited by 279 · see citing works

Redox dysregulation, neuroinflammation, and NMDA receptor hypofunction: A “central hub” in schizophrenia pathophysiology?

Steullet, P., Cabungcal, J. H., Monin, A., Dwir, D., O'Donnell, P., Cuenod, M., & Do, K. Q. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2014.06.021 · Cited by 262 · see citing works

Cytokines in bipolar disorder: A systematic review and meta-analysis

Munkholm, K., Vinberg, M., & Vedel Kessing, L. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.06.010 · Cited by 256 · see citing works

Effects of Exercise Training on the Autonomic Nervous System with a Focus on Anti-Inflammatory and Antioxidants Effects

Daniela, M., Luca, C. M., Onu, I., Paula, M., Iordan, D. A., & Buculei, I. (2022) · Antioxidants · doi:10.3390/antiox11020350 · Cited by 244 · see citing works

The neurobiology and treatment of first-episode schizophrenia

Kahn, R. S., & Sommer, I. E. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.66 · Cited by 219 · see citing works

NADPH oxidases: novel therapeutic targets for neurodegenerative diseases

Gao, H., Zhou, H., & Hong, J. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.03.008 · Cited by 212 · see citing works

Postmortem transcriptional profiling reveals widespread increase in inflammation in schizophrenia: a comparison of prefrontal cortex, striatum, and hippocampus among matched tetrads of controls with subjects diagnosed with schizophrenia, bipolar or major depressive disorder

Lanz, T. A., Reinhart, V., Sheehan, M. J., Rizzo, S. J. S., Bove, S. E., James, L. C., Volfson, D., Lewis, D. A., & Kleiman, R. J. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0492-8 · Cited by 209 · see citing works

Involvement of NOX2 in the Development of Behavioral and Pathologic Alterations in Isolated Rats

Schiavone, S., Sorce, S., Dubois-Dauphin, M., Jaquet, V., Colaianna, M., Zotti, M., Cuomo, V., Trabace, L., & Krause, K.-H. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.04.033 · Cited by 208 · see citing works

Juvenile Antioxidant Treatment Prevents Adult Deficits in a Developmental Model of Schizophrenia

Cabungcal, J.-H., Counotte, D. S., Lewis, E. M., Tejeda, H. A., Piantadosi, P., Pollock, C., Calhoon, G. G., Sullivan, E. M., Presgraves, E., Kil, J., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.07.028 · Cited by 204 · see citing works

Cytokine hypothesis of schizophrenia pathogenesis: Evidence from human studies and animal models

Watanabe, Y., Someya, T., & Nawa, H. (2010) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2010.02094.x · Cited by 204 · see citing works

Redox Dysregulation Affects the Ventral But Not Dorsal Hippocampus: Impairment of Parvalbumin Neurons, Gamma Oscillations, and Related Behaviors

Steullet, P., Cabungcal, J.-H., Kulak, A., Kraftsik, R., Chen, Y., Dalton, T. P., Cuenod, M., & Do, K. Q. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3857-09.2010 · Cited by 202 · see citing works

Parvalbumin interneuron vulnerability and brain disorders

Ruden, J. B., Dugan, L. L., & Konradi, C. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-020-0778-9 · Cited by 194 · see citing works

Inflammation in schizophrenia: A question of balance

Leza, J. C., García‐Bueno, B., Bioque, M., Arango, C., Parellada, M., Kim, Q., O’Donnell, P., & Bernardo, M. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.05.014 · Cited by 183 · see citing works

In vivo markers of inflammatory response in recent-onset schizophrenia: a combined study using [11C]DPA-713 PET and analysis of CSF and plasma

Coughlin, J. M., Wang, Y., Ambinder, E. B., Ward, R. E., Minn, I., Vranešić, M., Kim, P. K., Ford, C. N., Higgs, C. P., Hayes, L. N., et al. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.40 · Cited by 169 · see citing works

Behavioral and neurochemical consequences of cortical oxidative stress on parvalbumin-interneuron maturation in rodent models of schizophrenia

Powell, S. B., Sejnowski, T. J., & Behrens, M. M. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.01.049 · Cited by 164 · see citing works

Social isolation rearing induces mitochondrial, immunological, neurochemical and behavioural deficits in rats, and is reversed by clozapine or N-acetyl cysteine

Möller, M., du Preez, J. L., Viljoen, F. P., Berk, M., Emsley, R. A., & Harvey, B. H. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.12.011 · Cited by 168 · see citing works

Reactive Oxygen Species Scavenging Nanomedicine for the Treatment of Ischemic Heart Disease

Zhang, Z., Dalan, R., Hu, Z., Wang, J., Chew, N., Poh, K. K., Tan, R., Soong, T. W., Dai, Y., Ye, L., et al. (2022) · Advanced Materials · doi:10.1002/adma.202202169 · Cited by 174 · see citing works

IL-6 Mediated Degeneration of Forebrain GABAergic Interneurons and Cognitive Impairment in Aged Mice through Activation of Neuronal NADPH Oxidase

Dugan, L. L., Ali, S. S., Shekhtman, G., Roberts, A. J., Lucero, J., Quick, K. L., & Behrens, M. M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005518 · Cited by 165 · see citing works

Does schizophrenia arise from oxidative dysregulation of parvalbumin-interneurons in the developing cortex?

Behrens, M. M., & B, T. J. S. A. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.06.002 · Cited by 160 · see citing works

Implications for reactive oxygen species in schizophrenia pathogenesis

Koga, M., Serritella, A. V., Sawa, A., & Sedlak, T. W. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.06.022 · Cited by 159 · see citing works

NADPH oxidases in Parkinson’s disease: a systematic review

Bélarbi, K., Cuvelier, E., Destée, A., Gressier, B., & Chartier‐Harlin, M. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0225-5 · Cited by 158 · see citing works

Adolescent Onset of Cortical Disinhibition in Schizophrenia: Insights From Animal Models

O'Donnell, P. (2011) · Schizophrenia Bulletin · doi:10.1093/schbul/sbr028 · Cited by 145 · see citing works

MMP9/RAGE pathway overactivation mediates redox dysregulation and neuroinflammation, leading to inhibitory/excitatory imbalance: a reverse translation study in schizophrenia patients

Dwir, D., Giangreco, B., Xin, L., Tenenbaum, L., Cabungcal, J.-H., Steullet, P., Goupil, A., Cleusix, M., Jenni, R., Chtarto, A., et al. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0393-5 · Cited by 137 · see citing works

Modulating neuroinflammation and oxidative stress to prevent epilepsy and improve outcomes after traumatic brain injury

Eastman, C. L., D’Ambrosio, R., & Ganesh, T. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107907 · Cited by 137 · see citing works

The Cytokine Model of Schizophrenia: Emerging Therapeutic Strategies

Girgis, R. R., Kumar, S. S., & Brown, A. S. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.12.002 · Cited by 135 · see citing works

Social Isolation Exacerbates Schizophrenia-Like Phenotypes via Oxidative Stress in Cortical Interneurons

Jiang, Z., Rompala, G. R., Zhang, S., Cowell, R. M., & Nakazawa, K. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.12.004 · Cited by 128 · see citing works

Which NADPH Oxidase Isoform Is Relevant for Ischemic Stroke? The Case for Nox 2

Kahles, T., & Brandes, R. P. (2013) · Antioxidants &amp; Redox Signaling · doi:10.1089/ars.2012.4721 · Cited by 125 · see citing works

Neurobiological Consequences of Sleep Deprivation

Alkadhi, K. A., Zagaar, M. A., Alhaider, I. A., Salim, S., & Aleisa, A. M. (2013) · Current Neuropharmacology · doi:10.2174/1570159x11311030001 · Cited by 121 · see citing works

A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Tocilizumab, An Interleukin-6 Receptor Antibody, For Residual Symptoms in Schizophrenia

Girgis, R. R., Ciarleglio, A., Choo, T. H., Haynes, G., Bathon, J. M., Cremers, S., Kantrowitz, J. T., Lieberman, J. A., & Brown, A. S. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.258 · Cited by 119 · see citing works

Selenium, selenoprotein P, and Alzheimer's disease: is there a link?

Solovyev, N. D., Drobyshev, E. J., Bjørklund, G., Dubrovskii, Y. A., Lysiuk, R., & Rayman, M. P. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.02.030 · Cited by 114 · see citing works

1,8-Cineole (Eucalyptol) Mitigates Inflammation in Amyloid Beta Toxicated PC12 Cells: Relevance to Alzheimer’s Disease

Khan, A., Vaibhav, K., Javed, H., Tabassum, R., Ahmed, M. E., Khan, M. M., Khan, M. B., Shrivastava, P., Islam, F., Siddiqui, M. S., et al. (2013) · Neurochemical Research · doi:10.1007/s11064-013-1231-9 · Cited by 110 · see citing works

Mismatch negativity as a biomarker of theta band oscillatory dysfunction in schizophrenia

Javitt, D. C., Lee, M., Kantrowitz, J. T., & Martı́nez, A. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.06.023 · Cited by 112 · see citing works

Neuroendocrine profile in a rat model of psychosocial stress: Relation to oxidative stress

Colaianna, M., Schiavone, S., Zotti, M., Tucci, P., Morgese, M. G., Bäckdahl, L., Holmdahl, R., Krause, K.-H., Cuomo, V., & Trabace, L. (2013) · Antioxidants &amp; Redox Signaling · doi:10.1089/ars.2012.4569 · Cited by 107 · see citing works

Inflammation, mitochondria, and the inhibition of adult neurogenesis

Voloboueva, L. A., & Giffard, R. G. (2011) · Journal of Neuroscience Research · doi:10.1002/jnr.22768 · Cited by 106 · see citing works

The stress-induced cytokine interleukin-6 decreases the inhibition/excitation ratio in the rat temporal cortex via trans-signaling

Garcia-Oscos, F., Salgado, H., Hall, S., Thomas, F., Farmer, G. E., Bermeo, J., Galindo, L. C., Ramirez, R. D., D'Mello, S., Rose-John, S., et al. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.11.018 · Cited by 105 · see citing works

The rodent endovascular puncture model of subarachnoid hemorrhage: mechanisms of brain damage and therapeutic strategies

Kooijman, E., Nijboer, C. H. A., van Velthoven, C. T. J., Kavelaars, A., Kesecioğlu, J., & Heijnen, C. J. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-2 · Cited by 99 · see citing works

Cytokine Imbalance in Schizophrenia. From Research to Clinic: Potential Implications for Treatment

Reale, M., Costantini, E., & Greig, N. H. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.536257 · Cited by 98 · see citing works

NOX2 As a Target for Drug Development: Indications, Possible Complications, and Progress

Diebold, B. A., Smith, S. M., Yang, L., & Lambeth, J. D. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.5862 · Cited by 96 · see citing works

Pharmacological Regulation of Oxidative Stress in Stem Cells

Lee, J., Cho, Y. S., Jung, H., & Choi, I. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/4081890 · Cited by 94 · see citing works

The NADPH Oxidase NOX2 Controls Glutamate Release: A Novel Mechanism Involved in Psychosis-Like Ketamine Responses

Sorce, S., Schiavone, S., Tucci, P., Colaianna, M., Jaquet, V., Cuomo, V., Dubois‐Dauphin, M., Trabace, L., & Krause, K. H. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.1491-10.2010 · Cited by 92 · see citing works

Convergence of genetic and environmental factors on parvalbumin-positive interneurons in schizophrenia

Jiang, Z., Cowell, R. M., & Nakazawa, K. (2013) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2013.00116 · Cited by 89 · see citing works

Anti-inflammatory Strategies for Schizophrenia: A Review of Evidence for Therapeutic Applications and Drug Repurposing

Hong, J., & Bang, M. (2020) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2020.18.1.10 · Cited by 90 · see citing works

Estrogens and the cognitive symptoms of schizophrenia: Possible neuroprotective mechanisms

McGregor, C., Riordan, A. J., & Thornton, J. E. (2017) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2017.06.003 · Cited by 88 · see citing works

Elevated levels of IL-6 and IL-18 in manic and hypomanic states in rapid cycling bipolar disorder patients

Munkholm, K., Weikop, P., Kessing, L. V., & Vinberg, M. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.09.021 · Cited by 83 · see citing works

Risks Associated with Misuse of Ketamine as a Rapid-Acting Antidepressant

Zhu, W., Ding, Z., Zhang, Y., Shi, J., Hashimoto, K., & Lu, L. (2016) · Neuroscience Bulletin · doi:10.1007/s12264-016-0081-2 · Cited by 80 · see citing works

Carboxyfullerene neuroprotection postinjury in Parkinsonian nonhuman primates

Dugan, L. L., Tian, L., Quick, K. L., Hardt, J. I., Karimi, M., Brown, C., Loftin, S. K., Flores, H., Moerlein, S. M., Polich, J. M., et al. (2014) · Annals of Neurology · doi:10.1002/ana.24220 · Cited by 80 · see citing works

The role of glutamatergic inputs onto parvalbumin-positive interneurons: relevance for schizophrenia

Rotaru, D. C., Lewis, D. A., & González‐Burgos, G. (2012) · Reviews in the Neurosciences · doi:10.1515/revneuro-2011-0059 · Cited by 80 · see citing works

Involvement of GABAergic, BDNF and Nox-2 mechanisms in the prevention and reversal of ketamine-induced schizophrenia-like behavior by morin in mice

Ben‐Azu, B., Aderibigbe, A. O., Ajayi, A. M., Eneni, A.-E. O., Umukoro, S., & Iwalewa, E. O. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.03.006 · Cited by 79 · see citing works

Particulate Matter Induces Tissue OxInflammation: From Mechanism to Damage

Valacchi, G., Magnani, N., Woodby, B. L., Ferreira, S. M., & Evelson, P. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.8015 · Cited by 79 · see citing works

Sepsis-induced selective parvalbumin interneuron phenotype loss and cognitive impairments may be mediated by NADPH oxidase 2 activation in mice

Ji, M.-H., Qiu, L., Tang, H., Ju, L.-S., Sun, X.-R., Zhang, H., Jia, M., Zuo, Z., Shen, J.-C., & Yang, J. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0401-x · Cited by 79 · see citing works

Effects of Ketamine on Levels of Inflammatory Cytokines IL-6, IL-1β, and TNF-α in the Hippocampus of Mice Following Acute or Chronic Administration

Li, Y., Shen, R., Wen, G., Ding, R., Du, A., Zhou, J., Dong, Z., Ren, X., Yao, H., Zhao, R., et al. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00139 · Cited by 80 · see citing works

Targeting NOX enzymes in the central nervous system: therapeutic opportunities

Sorce, S., Krause, K., & Jaquet, V. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1014-5 · Cited by 78 · see citing works

NOX4 Expression in Human Microglia Leads to Constitutive Generation of Reactive Oxygen Species and to Constitutive IL-6 Expression

Li, B., Bedard, K., Sorce, S., Hinz, B., Dubois‐Dauphin, M., & Krause, K. (2009) · Journal of Innate Immunity · doi:10.1159/000235563 · Cited by 77 · see citing works

Prostate Cancer and Neuroendocrine Differentiation: More Neuronal, Less Endocrine?

Grigore, A. D., Ben‐Jacob, E., & Farach‐Carson, M. C. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00037 · Cited by 76 · see citing works

NADPH oxidase elevations in pyramidal neurons drive psychosocial stress-induced neuropathology

Schiavone, S., Jaquet, V., Sorce, S., Dubois‐Dauphin, M., Hultqvist, M. H., Bäckdahl, L., Holmdahl, R., Colaianna, M., Cuomo, V., Trabace, L., et al. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.36 · Cited by 75 · see citing works

Prefrontal Cortical Gamma-Aminobutyric Acid Transmission and Cognitive Function: Drawing Links to Schizophrenia from Preclinical Research

Tse, M., Piantadosi, P. T., & Floresco, S. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.09.007 · Cited by 73 · see citing works

Beyond the dopamine receptor: novel therapeutic targets for treating schizophrenia

Coyle, J. T., Balu, D. T., Benneyworth, M. A., Basu, A. C., & Roseman, A. S. (2010) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2010.12.3/jcoyle · Cited by 75 · see citing works

Inhibitory Interneurons, Oxidative Stress, and Schizophrenia

Sullivan, E. M., & O'Donnell, P. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs052 · Cited by 71 · see citing works

Prenatal maternal immune disruption and sex-dependent risk for psychoses

Goldstein, J. M., Cherkerzian, S., Seidman, L. J., Donatelli, J.-A. L., Remington, A., Tsuang, M. T., Hornig, M., & Buka, S. L. (2014) · Psychological Medicine · doi:10.1017/s0033291714000683 · Cited by 71 · see citing works

Disorders of Endogenous and Exogenous Antioxidants in Neurological Diseases

Korczowska-Łącka, I., Słowikowski, B. K., Piekut, T., Hurła, M., Banaszek, N., Szymanowicz, O., Jagodziński, P. P., Kozubski, W. P., Permoda-Pachuta, A., & Dorszewska, J. (2023) · Antioxidants · doi:10.3390/antiox12101811 · Cited by 76 · see citing works

Relationship between Interleukin-6 Gene Polymorphism and Hippocampal Volume in Antipsychotic-Naïve Schizophrenia: Evidence for Differential Susceptibility?

Kalmady, S. V., Venkatasubramanian, G., Shivakumar, V., Gautham, S., Subramaniam, A., Jose, D. A., Maitra, A., Ravi, V., & Gangadhar, B. N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096021 · Cited by 69 · see citing works

Interleukin-6-induced S100B secretion is inhibited by haloperidol and risperidone

de Souza, D. F., Wartchow, K. M., Hansen, F., Lunardi, P. S., Guerra, M. C., Nardin, P., & Gonçalves, C. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.12.001 · Cited by 69 · see citing works

Deletion of selenoprotein P results in impaired function of parvalbumin interneurons and alterations in fear learning and sensorimotor gating

Pitts, M. W., Raman, A. V., Hashimoto, A. C., Todorovic, C., Nichols, R. A., & Berry, M. J. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.02.017 · Cited by 67 · see citing works

Mangiferin ameliorates 6-hydroxydopamineinduced cytotoxicity and oxidative stress in ketamine model of schizophrenia

Rao, V. S. N., Carvalho, A. C. S., Trevisan, M. T. S., de Andrade, G. M., Júnior, H. V. N., de Moraes, M. O., Iury, H. I. M. H., Morais, T. C., & Santos, F. A. (2012) · Pharmacological Reports · doi:10.1016/s1734-1140(12)70879-4 · Cited by 66 · see citing works

Cognitive deterioration among bipolar disorder patients infected by Toxoplasma gondii is correlated to interleukin 6 levels

Hamdani, N., Daban, C., Lajnef, M., Gadel, R., Corvoisier, P. L., Delavest, M., Carde, S., Lépine, J., Jamain, S., Houenou, J., et al. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.03.038 · Cited by 65 · see citing works

The Use of microRNAs to Modulate Redox and Immune Response to Stroke

Ouyang, Y., Stary, C. M., White, R., & Giffard, R. G. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5757 · Cited by 60 · see citing works

Role of Mitochondria in the Redox Signaling Network and Its Outcomes in High Impact Inflammatory Syndromes

Magnani, N., Marchini, T., Calabró, V., Álvarez, S., & Evelson, P. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.568305 · Cited by 64 · see citing works

Combination of prenatal immune challenge and restraint stress affects prepulse inhibition and dopaminergic/GABAergic markers

Deslauriers, J., Larouche, A., Sarret, P., & Grignon, S. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.05.006 · Cited by 61 · see citing works

Neuroglialpharmacology: white matter pathophysiologies and psychiatric treatments

Bartzokis, G. (2011) · Frontiers in bioscience · doi:10.2741/3881 · Cited by 60 · see citing works

Neurodevelopmental Animal Models Reveal the Convergent Role of Neurotransmitter Systems, Inflammation, and Oxidative Stress as Biomarkers of Schizophrenia: Implications for Novel Drug Development

Möller, M., Swanepoel, T., & Harvey, B. H. (2015) · ACS Chemical Neuroscience · doi:10.1021/cn5003368 · Cited by 59 · see citing works

Repeated psychosocial stress causes glutamic acid decarboxylase isoform-67, oxidative-Nox-2 changes and neuroinflammation in mice: Prevention by treatment with a neuroactive flavonoid, morin

Ben‐Azu, B., Emokpae, O., Ajayi, A. M., Jarikre, T. A., Orhode, V., Aderibigbe, A. O., Umukoro, S., & Iwalewa, E. O. (2020) · Brain Research · doi:10.1016/j.brainres.2020.146917 · Cited by 57 · see citing works

Neonatal Intrahippocampal Immune Challenge Alters Dopamine Modulation of Prefrontal Cortical Interneurons in Adult Rats

Feleder, C., Tseng, K. Y., Calhoon, G. G., & O'Donnell, P. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.028 · Cited by 57 · see citing works

Mitochondrial Protection Attenuates Inflammation-Induced Impairment of NeurogenesisIn VitroandIn Vivo

Voloboueva, L. A., Lee, S. W., Emery, J. F., Palmer, T. D., & Giffard, R. G. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.1752-10.2010 · Cited by 57 · see citing works

Dynamic Optical Imaging of Metabolic and NADPH Oxidase-Derived Superoxide in Live Mouse Brain Using Fluorescence Lifetime Unmixing

Hall, D. J., Han, S.-H., Chepetan, A. M., Inui, E. G., Rogers, M., & Dugan, L. L. (2011) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2011.119 · Cited by 56 · see citing works

Cytokines in schizophrenia: Possible role of anti‐inflammatory medications in clinical and preclinical stages

Mansur, R. B., Zugman, A., Asevedo, E. D. M., da Cunha, G. R., Bressan, R. A., & Brietzke, E. M. (2012) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2012.02354.x · Cited by 55 · see citing works

Early Loss of Blood-Brain Barrier Integrity Precedes NOX2 Elevation in the Prefrontal Cortex of an Animal Model of Psychosis

Schiavone, S., Mhillaj, E., Neri, M., Morgese, M. G., Tucci, P., Bove, M., Valentino, M., Di Giovanni, G., Pomara, C., Turillazzi, E., et al. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-9791-8 · Cited by 55 · see citing works

NOX2 Mediated-Parvalbumin Interneuron Loss Might Contribute to Anxiety-Like and Enhanced Fear Learning Behavior in a Rat Model of Post-Traumatic Stress Disorder

Liu, F., Yang, L., Sun, X., Zhang, H., Pan, W. X., Wang, X., Yang, J., Ji, M., & Yuan, H. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9571-x · Cited by 54 · see citing works

Ribonucleic Acid Interference Knockdown of Interleukin 6 Attenuates Cold-Induced Hypertension

Crosswhite, P. L., & Sun, Z. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.146902 · Cited by 53 · see citing works

Long-term effects of ionising radiation on the brain: cause for concern?

Kempf, S. J., Azimzadeh, O., Atkinson, M. J., & Tapio, S. (2012) · Radiation and Environmental Biophysics · doi:10.1007/s00411-012-0436-7 · Cited by 52 · see citing works

Cortical disinhibition in the neonatal ventral hippocampal lesion model of schizophrenia: New vistas on possible therapeutic approaches

O’Donnell, P. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.07.005 · Cited by 52 · see citing works

Doxycycline prevents and reverses schizophrenic-like behaviors induced by ketamine in mice via modulation of oxidative, nitrergic and cholinergic pathways

Ben‐Azu, B., Omogbiya, I. A., Aderibigbe, A. O., Umukoro, S., Ajayi, A. M., & Iwalewa, E. O. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.02.007 · Cited by 52 · see citing works

Transcriptomic evidence for immaturity of the prefrontal cortex in patients with schizophrenia

Hagihara, H., Ohira, K., Takao, K., & Miyakawa, T. (2014) · Molecular Brain · doi:10.1186/1756-6606-7-41 · Cited by 52 · see citing works

Chronic Treatment with Fluoxetine or Clozapine of Socially Isolated Rats Prevents Subsector-Specific Reduction of Parvalbumin Immunoreactive Cells in the Hippocampus

Filipović, D., Stanisavljević, A., Jasnic, N. I., Bernardi, R. E., Inta, D., Perić, I., & Gass, P. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.12.020 · Cited by 49 · see citing works

Development/Plasticity/Repair Interleukin-6 Mediates the Increase in NADPH-Oxidase in the Ketamine Model of Schizophrenia

Behrens, M. M., Ali, S. S., & Dugan, L. L. (2015)

Ketamine-Induced Loss of Phenotype of Fast-Spiking Interneurons Is Mediated by NADPH-Oxidase

Behrens, M. M., Ali, S. S., Dao, D. N., Lucero, J., Shekhtman, G., Quick, K. L., & Dugan, L. L. (2007) · Science · doi:10.1126/science.1148045 · Cited by 585 · see citing works

Ketamine Findings Suggest Path to New Schizophrenia Drugs

Moran, M. (2008) · Psychiatric News · doi:10.1176/pn.43.2.0034

Drugs, Psychosis, and Schizophrenia

Stern, P. (2007) · Science s STKE · doi:10.1126/stke.4162007tw451

Acute ketamine induces neuronal hyperexcitability and deficits in prepulse inhibition by upregulating IL-6

Luo, Y., Yang, Y., He, H., & Fan, N. (2023) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2023.110913 · Cited by 6 · see citing works